BCL2L1 and breast carcinoma: In contrast to the observation that Bcl-2/Bcl-xL were primarily expressed in ER-positive breast cancer cells [26], we found that MDA-MB-231 TNBC cells exhibited much higher level of Bcl-2 and Bcl-xL compared to ER-positive MCF-7 breast cancer cells.